Amnon Peled

13.6k total citations · 3 hit papers
138 papers, 10.3k citations indexed

About

Amnon Peled is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Amnon Peled has authored 138 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Oncology, 73 papers in Immunology and 40 papers in Hematology. Recurrent topics in Amnon Peled's work include Chemokine receptors and signaling (54 papers), Immunotherapy and Immune Responses (41 papers) and Immune Cell Function and Interaction (28 papers). Amnon Peled is often cited by papers focused on Chemokine receptors and signaling (54 papers), Immunotherapy and Immune Responses (41 papers) and Immune Cell Function and Interaction (28 papers). Amnon Peled collaborates with scholars based in Israel, United States and France. Amnon Peled's co-authors include Arnon Nagler, Tsvee Lapidot, Isabelle Petit, Dov Zipori, R. Alon, Jan A. Burger, Órit Kollet, Ori Wald, Eithan Galun and Herzl Ben‐Hur and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Amnon Peled

134 papers receiving 10.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4

1999 1.4k citations Amnon Peled, Arnon Nagler et al. profile →
G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4

2002 1.1k citations Arnon Nagler, Amnon Peled et al. profile →
The chemokine SDF-1 activates the integrins LFA-1, VLA-4, and VLA-5 on immature human CD34+ cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice

2000 603 citations Amnon Peled, Arnon Nagler et al. Blood profile →

Peers

Countries citing papers authored by Amnon Peled

Since Specialization

Citations

This map shows the geographic impact of Amnon Peled's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amnon Peled with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amnon Peled more than expected).

Fields of papers citing papers by Amnon Peled

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amnon Peled. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amnon Peled. The network helps show where Amnon Peled may publish in the future.

Co-authorship network of co-authors of Amnon Peled

This figure shows the co-authorship network connecting the top 25 collaborators of Amnon Peled. A scholar is included among the top collaborators of Amnon Peled based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amnon Peled. Amnon Peled is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1 2025 ·Frontiers in Immunology ·Shira Hagbi-Levi, Michal Abraham, (unknown), (unknown), (unknown), (unknown), Ori Wald, Hanna Wald, Devorah Olam, (unknown), Amnon Peled	0
2	Short treatment of peripheral blood cells product with Fas ligand using closed automated cell processing system significantly reduces immune cell reactivity of the graft in vitro and in vivo 2022 ·Bone Marrow Transplantation ·(unknown), (unknown), (unknown), (unknown), (unknown), Elina Zorde‐Khvalevsky, Amnon Peled, Shai Yarkoni, (unknown)	2
3	Multiple Roles of IL6 in Hepatic Injury, Steatosis, and Senescence Aggregate to Suppress Tumorigenesis 2021 ·Cancer Research ·Anat Shriki, (unknown), Amir Sonnenblick, (unknown), (unknown), Rinat Abramovitch, Nofar Rosenberg, Orit Pappo, Sharona Elgavish, Yuval Nevo, Rifaat Safadi, Amnon Peled, Stefan Rose‐John, Eithan Galun, Jonathan H. Axelrod	16
4	CCL24 modulates fibrosis development in primary sclerosing cholangitis: correlation of human serum CCL24 levels with fibrosis markers and data from the Mdr2–/– mouse model. 2020 ·Journal of Hepatology ·Neta Barashi, Michal Segal, (unknown), (unknown), Adi Mor, Inbal Mishalian, Devorah Olam, Amnon Peled, Francesca Saffioti, Douglas Thorburn	1
5	Brief ex vivo Fas-ligand incubation attenuates GvHD without compromising stem cell graft performance 2020 ·Bone Marrow Transplantation ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michal Abraham, Inbal Mishalian, (unknown), Tamar Katz, (unknown), Shai Yarkoni, (unknown), Amnon Peled, Tsila Zuckerman, Jerry Stein	2
6	Blocking of Transient Receptor Potential Vanilloid 1 (TRPV1) promotes terminal mitophagy in multiple myeloma, disturbing calcium homeostasis and targeting ubiquitin pathway and bortezomib-induced unfolded protein response 2020 ·Journal of Hematology & Oncology ·Katia Beider, (unknown), (unknown), (unknown), (unknown), Hila Magen, Olga Ostrovsky, Avichai Shimoni, Zohar Bromberg, Lola Weiss, Amnon Peled, Arnon Nagler	38
7	Single Dose of the CXCR4 Antagonist BL-8040 Induces Rapid Mobilization for the Collection of Human CD34+ Cells in Healthy Volunteers 2017 ·Clinical Cancer Research ·Michal Abraham, Yaron Pereg, Baruch Bulvik, Shiri Klein, Inbal Mishalian, (unknown), Orly Eizenberg, Katia Beider, Arnon Nagler, (unknown), (unknown), (unknown), Eithan Galun, Yoseph Caraco, Reuven Or, Amnon Peled	41
8	CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1–Mediated ERK and BCL2/Cyclin D1 Pathways 2017 ·Cancer Research ·Shiri Klein, Michal Abraham, Baruch Bulvik, (unknown), Ido D. Weiss, Neta Barashi, Rinat Abramovitch, Hanna Wald, (unknown), Devorah Olam, Lola Weiss, Katia Beider, Orly Eizenberg, Ori Wald, Eithan Galun, Yaron Pereg, Amnon Peled	48
9	Enhanced In Vivo Persistence and Proliferation of NK Cells Expanded in Culture with the Small Molecule Nicotinamide: Development of a Clinical-Applicable Method for NK Expansion 2017 ·Blood ·Tony Peled, Guy Brachya, (unknown), (unknown), (unknown), Efrat Landau, (unknown), Amnon Peled, Jeffrey S. Miller, Veronika Bachanová	7
10	The Sphingosine-1-Phosphate Modulator FTY720 Targets Multiple Myeloma via the CXCR4/CXCL12 Pathway 2016 ·Clinical Cancer Research ·Katia Beider, (unknown), (unknown), Avichai Shimoni, Merav Leiba, Maya Koren‐Michowitz, Elena Ribakovsky, Shiri Klein, Devorah Olam, Lola Weiss, Hanna Wald, Michal Abraham, Eithan Galun, Amnon Peled, (unknown)	33
11	Combination of Imatinib with CXCR4 Antagonist BKT140 Overcomes the Protective Effect of Stroma and Targets CML In Vitro and In Vivo 2014 ·Molecular Cancer Therapeutics ·Katia Beider, Merav Darash‐Yahana, (unknown), Maya Koren‐Michowitz, Michal Abraham, Hanna Wald, Ori Wald, Eithan Galun, Orly Eizenberg, Amnon Peled, Arnon Nagler	51
12	The High-Affinity CXCR4 Antagonist BKT140 Is Safe and Induces a Robust Mobilization of Human CD34+ Cells in Patients with Multiple Myeloma 2013 ·Clinical Cancer Research ·Amnon Peled, Michal Abraham, Irit Avivi, Jacob M. Rowe, Katia Beider, Hanna Wald, (unknown), (unknown), (unknown), (unknown), (unknown), Eithan Galun, (unknown), Orly Eizenberg, Izhar Hardan, Avichai Shimoni, Arnon Nagler	70
13	Targeting the CD20 and CXCR4 Pathways in Non-Hodgkin Lymphoma with Rituximab and High-Affinity CXCR4 Antagonist BKT140 2013 ·Clinical Cancer Research ·Katia Beider, Elena Ribakovsky, Michal Abraham, Hanna Wald, Lola Weiss, (unknown), Eithan Galun, Abraham Avigdor, Orly Eizenberg, Amnon Peled, Arnon Nagler	48
14	Development of novel CXCR4-based therapeutics 2012 ·Expert Opinion on Investigational Drugs ·Amnon Peled, Ori Wald, Jan A. Burger	64
15	Adhesion of Hairy Cells Leukemia (HCL) Cells to Stromal Cells Can Be Inhibited by Blocking VLA-4 Integrins and CXCR4 Chemokine Receptors 2011 ·Blood ·Mariela Sivina, Robert J. Kreitman, Amnon Peled, Farhad Ravandi, Jan A. Burger	10
16	IFN-γ Acts on T Cells to Induce NK Cell Mobilization and Accumulation in Target Organs 2006 ·The Journal of Immunology ·Ori Wald, Ido D. Weiss, Hanna Wald, Hadas Shoham, (unknown), Katia Beider, Eithan Galun, Lola Weiss, Liat Flaishon, Idit Shachar, Arnon Nagler, Bao Lu, Craig Gérard, Ji‐Liang Gao, Eyal Mishani, Joshua Μ. Farber, Amnon Peled	77
17	Critical Involvement of the Chemotactic Axis CXCR4/Stromal Cell-Derived Factor-1α in the Inflammatory Component of Allergic Airway Disease 2000 ·The Journal of Immunology ·José-Ángel Gonzalo, Clare M. Lloyd, Amnon Peled, Tracy Delaney, Anthony J. Coyle, José-Carlos Gutierrez-Ramos	161
18	The Murine C′-Terminally Alternatively Spliced Form of p53 Induces Attenuated Apoptosis in Myeloid Cells 1997 ·Molecular and Cellular Biology ·Nava Almog, Runzhao Li, Amnon Peled, Dov Schwartz, Roland Wolkowicz, Naomi Goldfinger, Huiping Pei, Varda Rotter	24
19	SA-1, a nuclear protein encoded by one member of a novel gene family: molecular cloning and detection in hemopoietic organs 1997 ·Gene ·Laura Carramolino, (unknown), Ángel Zaballos, Amnon Peled, Isabel Barthelemy, Yaron Shav‐Tal, Ignacio Priéto, Pnina Carmi, Yaël Gothelf, Gonzalo González de Buitrago, Miguel Aracil, Gabriel Márquez, José Luís Barbero, Dov Zipori	38
20	Thy-1 antigen-mediated adhesion of mouse lymphoid cells to stromal cells of haemopoetic origin 1992 ·Immunology Letters ·(unknown), Amnon Peled	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact